Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Request Free Sample
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.
Speak to Analyst

Rectovaginal Fistula Market Research Report Information by Diagnosis (Physical Exam, Contrast Tests, Blue Dye Test, Computerized Tomography (CT) Scan) By Treatment (Medications, Surgery) By End User (Hospitals & Clinics, Diagnostic Centers) - Forecast Till 2032


ID: MRFR/HC/5672-HCR | 90 Pages | Author: Kinjoll Dey| April 2024

Rectovaginal Fistula Market Overview


The Rectovaginal fistula market size is anticipated to reach USD 623 Million by 2032 at 6.28% CAGR during the forecast period 2023-2032, says Market Research Future. Rectovaginal fistula is abnormal connection between lower portion of large intestine- rectum-vagina. There are various causes of rectovaginal fistula such as Crohn's disease, cancer or radiation treatment in pelvic area, surgery involving vagina, perineum, rectum or anus, injuries during childbirth, and others.


The factors such as increasing prevalence pelvic cancer, Crohn’s disease is the major driving factors for the market. Moreover, increasing adoption of personalized medicine, as personalised medicine has many applications in cancer treatment. Furthermore, growing diagnosis methods for rectovaginal fistula will boost the market growth during forecast period.


However, high cost of the surgery may hamper the growth of the market during the forecast period.


According to National Cancer Institute, in 2018, an estimated 1,735,350 new cases of cancer were diagnosed in the United States and 609,640 people may die from the disease.


Segmentation


The rectovaginal fistula market has been segmented into diagnosis, treatment, and end user.


By diagnosis, the market has been segmented into physical exam, contrast tests, blue dye test, computerized tomography (CT) scan, magnetic resonance imaging (MRI), anorectal ultrasound, anorectal manometry, and others.


Based on treatment, the market has been segmented into medications and surgery. Medications is further segmented into antibiotics and infliximab. Surgery is further segmented into sewing an anal fistula plug or patch of biologic tissue into the fistula, using a tissue graft, repairing the anal sphincter muscles, performing a colostomy before repairing a fistula in complex or recurrent cases.


The rectovaginal fistula market, by end user, has been segmented into hospitals & clinics, diagnostic centres, academic institutions and research organizations, and others.


The rectovaginal fistula market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The rectovaginal fistula market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.  


The European rectovaginal fistula market has been segmented into Western Europe and Eastern Europe. The Western Europe rectovaginal fistula market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.   


The rectovaginal fistula market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The rectovaginal fistula market in the Middle East & Africa has been segmented into the Middle East and Africa.    


Key players


Cook Medical, Takeda Pharmaceutical Company, Johnson & Johnson Services Inc., Pfizer Inc., Allergan, AbbVie Inc, Novartis International AG, Bayer AG, Bristol-Myers Squibb, Boehringer Ingelheim GmbH, F. Hoffmann-La Roche, Eli Lilly and Company, GlaxoSmithKline plc, Sanofi S.A are some of the prominent players in the rectovaginal fistula market.


Regional Market Summary


Global Rectovaginal Fistula Share (%), by Region


Rectovaginal Fistula Market Share


Source: White Papers, Company Presentations, Annual Reports


Geographically, the Americas is anticipated to dominate the rectovaginal fistula market owing to the high domestic income, and presence of major market players. Moreover, increasing patient population in US. According to American Cancer Society, the overall estimate of 1,735,350 cases for 2018 equals more than 4,700 new cancer diagnoses each day.


Europe is expected to hold the second largest position in the Dural Arteriovenous Fistulas Treatment market. The market growth in this region is attributed to the presence of strong academic & research base and availability of funding for research in the European countries. For instance, the European Research Council (ERC) provides grants for technological and scientific research conducted within the European Union (EU). 


The rectovaginal fistula market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to increasing government focus on biotechnology and pharmaceutical sector and growing number of target population in the region.   


The Middle East & Africa has the lowest share of the rectovaginal fistula market. Majority of the market of the region is anticipated to be held by the Middle East region owing to the growing government initiatives for the healthcare sector. 


Market of Rectovaginal Fistula, by Diagnosis:



  • Physical Exam

  • Contrast Tests

  • Blue Dye Test

  • Computerized Tomography (CT) Scan

  • Magnetic Resonance Imaging (MRI)

  • Anorectal Ultrasound

  • Anorectal Manometry

  • Others


Market of Rectovaginal Fistula, by Treatment:



  • Medications


    • Antibiotics

    • Infliximab


  • Surgery


    • Sewing an Anal Fistula Plug or Patch of Biologic Tissue into the Fistula

    • Using a Tissue Graft

    • Repairing the Anal Sphincter Muscles

    • Performing a Colostomy before Repairing a Fistula in Complex or Recurrent Cases



Market of Rectovaginal Fistula, by End User:



  • Hospitals & Clinics

  • Diagnostic Centers

  • Academic Institutions and Research Organizations

  • Others


Market of Rectovaginal Fistula, by Region:



  • Americas


    • North America


      • US

      • Canada


    • Latin America


  • Europe


    • Western Europe


      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe


    • Eastern Europe


  • Asia-Pacific


    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific


  • The Middle East & Africa


    • Middle East

    • Africa



Market of Rectovaginal Fistula, by Key Players:



  • Cook Medical

  • Takeda Pharmaceutical Company

  • Johnson & Johnson Services Inc.

  • Pfizer Inc.

  • Allergan

  • AbbVie Inc

  • Novartis International AG

  • Bayer AG

  • Bristol-Myers Squibb

  • Boehringer Ingelheim GmbH

  • Hoffmann-La Roche

  • Eli Lilly and Company

  • GlaxoSmithKline plc

  • Sanofi S.A

  • Others


Intended Audience:



  • Pharmaceutical and Biotechnological Companies

  • Contract Research Organizations

  • Academic and Research Institutes

  • Government Associations

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Request Free Sample
Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.
Ask for Customization